These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 128547)

  • 21. Spectinomycin modification. III. Spectinomycin analogs with C-3'-branched chain sugars.
    Thomas RC; Fritzen EL
    J Antibiot (Tokyo); 1985 Feb; 38(2):208-19. PubMed ID: 3158631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of impurities in commercial spectinomycin by liquid chromatography with electrospray ionization tandem mass spectrometry.
    Wang Y; Wang M; Li J; Yao S; Xue J; Zou W; Hu C
    J Antibiot (Tokyo); 2014 Jul; 67(7):511-8. PubMed ID: 24736854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections.
    Bruhn DF; Waidyarachchi SL; Madhura DB; Shcherbakov D; Zheng Z; Liu J; Abdelrahman YM; Singh AP; Duscha S; Rathi C; Lee RB; Belland RJ; Meibohm B; Rosch JW; Böttger EC; Lee RE
    Sci Transl Med; 2015 May; 7(288):288ra75. PubMed ID: 25995221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenylylation of trospectomycin by crude enzyme preparations from Escherichia coli.
    Yagi Y; Baczynskyj L; Mizsak SA; Argoudelis AD
    J Antibiot (Tokyo); 1988 Oct; 41(10):1452-61. PubMed ID: 2973455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spenolimycin, a new spectinomycin-type antibiotic. III. Biological properties.
    Fernandes PB; Vojtko CM; Bower RR; Weisz J
    J Antibiot (Tokyo); 1984 Dec; 37(12):1525-7. PubMed ID: 6241193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectinomycin modification. I. Catalytic N-demethylation of spectinomycin.
    Thomas RC
    J Antibiot (Tokyo); 1982 Sep; 35(9):1202-7. PubMed ID: 6216235
    [No Abstract]   [Full Text] [Related]  

  • 27. Spectinomycin modification. II. Spectinomycin C-3'-modification via diazoketone intermediates.
    Thomas RC; Fritzen EL
    J Antibiot (Tokyo); 1985 Feb; 38(2):197-207. PubMed ID: 3158630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spectinomycin-dehydrochloride-pentahydrate--introduction of a substance].
    Brunnberg FJ
    Z Hautkr; 1977; Suppl 1():1-3. PubMed ID: 142380
    [No Abstract]   [Full Text] [Related]  

  • 29. In-vitro activity of trospectomycin, a new aminocyclitol antibiotic, against multidrug-resistant Enterococcus faecium.
    Mobarakai N; Landman D; Quale JM
    J Antimicrob Chemother; 1994 Feb; 33(2):319-21. PubMed ID: 8182013
    [No Abstract]   [Full Text] [Related]  

  • 30. Carbon-13 NMR spectroscopy and its application to biological systems.
    Grutzner JB
    Lloydia; 1972 Dec; 35(4):375-98. PubMed ID: 4267251
    [No Abstract]   [Full Text] [Related]  

  • 31. Spenolimycin, a new spectinomycin-type antibiotic. I. Discovery, taxonomy and fermentation.
    Karwowski JP; Jackson M; Bobik TA; Prokop JF; Theriault RJ
    J Antibiot (Tokyo); 1984 Dec; 37(12):1513-8. PubMed ID: 6241191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity against aerobes and anaerobes of trospectomycin versus spectinomycin.
    Gismondo MR; Chisari G; Lo Bue AM
    Drugs Exp Clin Res; 1991; 17(2):101-4. PubMed ID: 1830841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro activity of trospectromycin against gram-positive cocci.
    Beam TR; Gorzynski EA; Rotstein C; Amsterdam D
    J Antimicrob Chemother; 1995 Nov; 36(5):874-8. PubMed ID: 8626271
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro activity of trospectomycin against methicillin-resistant Staphylococcus aureus and enterococci.
    Flournoy DJ; Koester JF
    Methods Find Exp Clin Pharmacol; 1992; 14(6):483-4. PubMed ID: 1469958
    [No Abstract]   [Full Text] [Related]  

  • 35. In-vitro activity of trospectomycin against enterococci isolated from blood and other clinical materials.
    Watanakunakorn C
    J Antimicrob Chemother; 1991 Jun; 27(6):873-5. PubMed ID: 1834622
    [No Abstract]   [Full Text] [Related]  

  • 36. Spectinomycin.
    Holloway WJ
    Med Clin North Am; 1982 Jan; 66(1):169-73. PubMed ID: 6460907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance Contributions.
    Liu J; Bruhn DF; Lee RB; Zheng Z; Janusic T; Scherbakov D; Scherman MS; Boshoff HI; Das S; Rakesh ; Waidyarachchi SL; Brewer TA; Gracia B; Yang L; Bollinger J; Robertson GT; Meibohm B; Lenaerts AJ; Ainsa J; Böttger EC; Lee RE
    ACS Infect Dis; 2017 Jan; 3(1):72-88. PubMed ID: 28081607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro activity of trospectomycin sulphate against Mycoplasma and Ureaplasma species isolated from humans.
    Yancey RJ; Klein LK
    J Antimicrob Chemother; 1988 Jun; 21(6):731-6. PubMed ID: 2970452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotics and chemotherapeutic agents--from research to practice. VII. Some remarks to practitioners on the properties of polymyxins, lincosanides, spectinomycin, synergistines, bacitracin, novobiocin and flavomycin].
    Pilloud M
    Schweiz Arch Tierheilkd; 1983 Jun; 125(6):371-82. PubMed ID: 6310738
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of synergy between vancomycin and trospectomycin against enterococci isolated from blood cultures.
    Watanakunakorn C
    J Antimicrob Chemother; 1992 Apr; 29(4):470-1. PubMed ID: 1535071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.